☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
cardiovascular disease
Novartis Signs an Agreement with NHS to Commercialize Leqvio (inclisiran) for the Treatment of Cardiovascular Disease
September 1, 2021
Bayer's Finerenone Demonstrates Positive Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes
November 18, 2020
AstraZeneca Acquires Dogma Therapeutics' Oral PCSK9 Inhibitor Program
September 18, 2020
Novo Nordisk to Acquire AstraZeneca's Spin-off Corvidia for ~$2.1B
June 12, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
